- Short Report
- Open Access
Clinical experience, infection control practices and diagnostic algorithms for poxvirus infections - an Emerging Infections Network survey
© Hughes et al; licensee BioMed Central Ltd. 2010
- Received: 5 February 2010
- Accepted: 25 February 2010
- Published: 25 February 2010
In order to determine how best to tailor outreach messages about poxvirus diagnosis and infection control for health practitioners, we surveyed infectious disease physicians in the Infectious Diseases Society of America's Emerging Infections Network.
Surveys consisting of two unknown case scenarios designed to raise suspicion for monkeypox and orf were distributed to the 1,080 members of the EIN. The surveys contained questions pertaining to which diagnostic tests, points of contact, and transmission precautions they would likely utilize during patient evaluation. Basic response rates and frequencies of responses were calculated. Comparisons of the survey responses were made using the chi-square test. Of the 212 members who responded (20% response rate), significantly more respondents indicated that they would request diagnostic testing in the context of the monkeypox case scenario as compared to the orf case scenario. A significantly higher number of respondents indicated they would institute droplet or airborne precautions for the monkeypox case as opposed to the orf case scenario.
This survey provided an opportunity for public health practitioners to gain insight into physician approaches to evaluation, diagnosis and reporting of suspected poxvirus-associated infections. This survey identified key areas in which public health practitioners can better serve physicians by focusing on education. As a result we were able to identify potential knowledge gaps and deficits in the availability of useful resources to facilitate accurate case identification and management.
- Public Health Practitioner
- Infection Control Practice
- Infectious Disease Physician
- Smallpox Vaccine
- Molluscum Contagiosum
In the wake of the 2003 U.S. monkeypox outbreak and renewed concerns regarding bioterrorism, poxvirus infections have garnered increased attention from medical and public health professionals alike.
There are multiple poxviruses of significance to human health that occur in the United States. These include Molluscum contagiosum virus, which causes common viral infections of the skin, and various parapoxviruses, such as Orf virus and Pseudocowpox virus, which are zoonotic entities associated with domestic ruminants (e.g., sheep, goats, cattle). Human parapoxvirus infections occur primarily in rural communities, but may also occur in larger communities with live animal markets, petting zoos and small-scale animal husbandry . Inadvertent Vaccinia virus infections also occur in the United States. Vaccinia is the primary component of the smallpox vaccine and infections can occur following contact with a recent vaccinee or via exposure to the virus in a laboratory [2–4]. Additionally, the current oral rabies vaccine (ORV), used to prevent the spread of terrestrial rabies along the Eastern seaboard, consists of a recombinant vaccinia virus containing the rabies virus glycoprotein gene. Two human infections following contact with ORV has been reported [5–7].
Importation of poxviruses from abroad is also a concern. This occurred in 2003 when monkeypox infected African rodents were imported to the United States resulting in a outbreak of monkeypox [8, 9]. Monkeypox virus is a communicable orthopoxvirus which can cause systemic infections in humans similar to Variola virus (smallpox). This event marked the first time that human monkeypox infections had been observed in the Western Hemisphere. There have also been two reports of Tanapox virus (a yatapoxvirus) infections in travelers returning to the U.S. from Africa [10, 11]
Many poxvirus infections share common clinical features (e.g., vesiculo-pustular or nodular rash lesion characteristics) but have differing risks for person-to-person transmission, thus necessitating different infection control measures. Poxvirus infections can be confused with other infections or conditions. This underscores the importance of laboratory diagnostic evaluation when poxvirus infections are suspected. Diagnostic testing for poxvirus infections is available; however most are only available at specialized reference centers (e.g., Laboratory Response Network facilities, Centers for Disease Control and Prevention (CDC)).
We surveyed infectious disease physicians in the Infectious Diseases Society of America's (IDSA) Emerging Infections Network (EIN) to gather insight on current diagnostic and infection control practices for suspect poxviruses in order to tailor outreach messages to health practitioners. In addition, we sought to determine what resources were readily available to physicians to assist in evaluation of suspected poxvirus infections. This survey also allowed us to gain some insight into the frequency and spectrum of poxvirus infections seen by this network of consultants.
IDSA's EIN is a provider-based emerging infections sentinel network of adult and pediatric infectious disease consultants. This network was established through a Cooperative Agreement Program Award in 1995 from the CDC .
During February and March of 2007, surveys were distributed by e-mail and facsimile to the 1,080 EIN. Participants were encouraged to use any reference material they deemed necessary to complete the query and were allowed to log in and out of the survey if they required more time.
Since the first distribution of the survey resulted in a low response rate, respondents were given the option of omitting their name from the second round of distribution. They were also given a choice of submitting their state and practice type in lieu of their name. Therefore, since demographic data is linked by name, some respondents do not have linked demographic data.
Basic response rates for demographic variables and frequencies of specific responses for each survey question were calculated. Denominators varied for several questions as members did not always respond to all the survey questions. Comparisons of responders and non-responders, as well as comparisons in responses to the two case scenarios were made using the chi-square test. A p-value of less than 0.05 was considered statistically significant.
Geographic and practice characteristics of poxvirus survey respondents vs. entire EIN participant base
(n = 212), no.(%)
(n = 1076†), no.(%)
Type of practice
Adult & Pediatric
East North Central
West North Central
East South Central
West South Central
No. yrs practice
Diagnostic ordering preferences for the two case scenarios in the EIN poxvirus survey
In-house/local academic institution
Commercial reference lab
In-house/local academic institution
Commercial reference lab
In-house/local academic institution
Commercial reference lab
Significantly more respondents would order a serological test for the monkeypox case scenario (72.6%) than for the orf case (38.7%) (p < 0.0001). The majority indicated that they would likely utilize a state or federal lab for serologic testing in the context of the suspected monkeypox case (50%) and the suspected orf case (21.7%). A significantly higher number of respondents would also order a culture or histopathology for the monkeypox case (73.6%) in contrast to the orf case (43.9%) (p < 0.0001). An in-house or local academic lab was most likely to be picked for both case scenarios (46.7% and 31.6% respectively).
When respondents were asked whom they might report initial suspicion of poxvirus-associated illness, a significantly higher proportion of respondents indicated that they would report the suspected monkeypox case (88.2%) as opposed to the orf case (66.8%) (p < 0.0001), with most respondents choose the state or local health department as the first point of contact for either scenario.
This survey provided an opportunity for public health practitioners to gain insight into physician approaches to evaluation, diagnosis and reporting of suspected poxvirus-associated infections. As a result we were able to identify potential knowledge gaps and deficits in the availability of useful resources to facilitate accurate case identification and management.
One of the weaknesses of this study was a low survey response rate. Several factors could account for this. Anecdotal suggestions are that many potential responders felt they were being "tested" rather than queried, and different professional groups had different response rates. Those who did not teach and those with less then 10 years of experience had a significantly lower response rate. Infectious disease physicians with less experience are probably less likely to have encountered some of these uncommon diseases and thereby are less likely to see the relevance of this query. Response rates also varied between regions, which could be due to differences in poxviruses seen in these regions.
While this sample may not be representative of the country's infectious disease physicians, it likely encompasses the best informed and the least apt to be dissuaded by lack of immediate knowledge. Respondents were able to suggest appropriate infection control measures, such as a combination of standard, contact and droplet precautions for monkeypox and standard precautions for orf, and pursued reasonable reporting mechanisms. A large proportion of respondents did, however, indicate that they would institute higher then necessary transmission precautions for the orf case scenario. We found that respondents were not necessarily aware of diagnostic tests available or where to find them. However, the majority of respondents did indicate they would order diagnostic testing for both case scenarios.
The public health community can play a greater role in reinforcing messages to health practitioners to address appropriate infection control procedures when dealing with suspected cases of poxvirus infection. They can also play an active role in disseminating information about new diagnostic tests (such as PCR and serologic tests). In response to findings from the survey, EIN members were provided a survey report summarizing CDC recommendations for the various scenarios [Additional file 2]. We also produced a fact sheet containing information pertinent to which diagnostic tests are currently available at CDC and elsewhere for etiologic determination of poxvirus-associated infection [Additional file 3]. The findings from this survey will also help guide us in the redesign of CDC's poxvirus website. We will make infection control practices, diagnostic capabilities, and reporting mechanisms more readily available on the website for physicians.
Poxviruses occur across the U.S. and around the world. Infectious disease physicians may not be the first clinicians to see patients with suspected poxvirus infections, but many will be asked to provide expert advice and consultation. Infectious disease physicians should be provided with the necessary tools to make well-informed decisions regarding suspected cases of poxvirus infections. This survey identified key areas in which public health practitioners can better serve physicians by focusing on education. These key areas include infection control practices and knowledge of various diagnostic tests available for poxviruses. Similar knowledge gaps exist for other relatively rare diseases that could become more common in an outbreak setting. This type of survey could also be helpful in bringing attention to those gaps and providing innovative ways to keep physicians better informed.
The authors would like to thank Cynthia Goldsmith, Dr. Christopher Paddock, Whitni Davidson, Zach Braden, Dr. Victoria Olson and Scott Smith for help with the poxvirus diagnostic handout.
The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the CDC.
- Steinhart B: Orf in humans: dramatic but benign. CJEM. 2005, 7: 417-419.PubMedGoogle Scholar
- Laboratory-acquired vaccinia exposures and infections--United States, 2005-2007. MMWR Morb Mortal Wkly Rep. 2008, 57: 401-404.Google Scholar
- Vulvar vaccinia infection after sexual contact with a military smallpox vaccinee--Alaska, 2006. MMWR Morb Mortal Wkly Rep. 2007, 56: 417-419.Google Scholar
- Vora S, Damon I, Fulginiti V, Weber SG, Kahana M, Stein SL, Gerber SI, Garcia-Houchins S, Lederman E, Hruby D: Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis. 2008, 46: 1555-1561. 10.1086/587668.PubMedView ArticleGoogle Scholar
- McGuill MW, Kreindel SM, DeMaria A, Robbins AH, Rowell S, Hanlon CA, Rupprecht CE: Human contact with bait containing vaccine for control of rabies in wildlife. J Am Vet Med Assoc. 1998, 213: 1413-1417.PubMedGoogle Scholar
- Rupprecht CE, Blass L, Smith K, Orciari LA, Niezgoda M, Whitfield SG, Gibbons RV, Guerra M, Hanlon CA: Human infection due to recombinant vaccinia-rabies glycoprotein virus. N Engl J Med. 2001, 345: 582-586. 10.1056/NEJMoa010560.PubMedView ArticleGoogle Scholar
- Human vaccinia infection after contact with a raccoon rabies vaccine bait - Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep. 2009, 58: 1204-1207.Google Scholar
- Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, Kazmierczak JJ, Stratman EJ, Li Y, Fairley JA: The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004, 350: 342-350. 10.1056/NEJMoa032299.PubMedView ArticleGoogle Scholar
- Reynolds MG, Yorita KL, Kuehnert MJ, Davidson WB, Huhn GD, Holman RC, Damon IK: Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis. 2006, 194: 773-780. 10.1086/505880.PubMedView ArticleGoogle Scholar
- Croitoru AG, Birge MB, Rudikoff D, Tan MH, Phelps RG: Tanapox virus infection. Skinmed. 2002, 1: 156-157. 10.1111/j.1540-9740.2002.01778.x.PubMedView ArticleGoogle Scholar
- Dhar AD, Werchniak AE, Li Y, Brennick JB, Goldsmith CS, Kline R, Damon I, Klaus SN: Tanapox infection in a college student. N Engl J Med. 2004, 350: 361-366. 10.1056/NEJMoa031467.PubMedView ArticleGoogle Scholar
- The emerging infections network: a new venture for the Infectious Diseases Society of America. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network. Clin Infect Dis. 1997, 25: 34-36. 10.1086/514511.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.